Objectives Omicron appears to lead to a milder illness for patients compared with previous
COVID-19 variants. However, not all infected with Omicron would describe their illness as mild…

Only a few studies have assessed the long-term duration of the humoral immune response
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recently, an …

We conducted a second nationwide severe acute respiratory syndrome coronavirus 2
seroprevalence study in the Faroe Islands during November 2020. We found crude …

Immunity following infection and vaccination with the SARS-CoV-2 Omicron variant is poorly
understood. The aim was to investigate immunity assessed with antibody response, …

Only a few studies have assessed the long-term duration of the humoral immune response
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this nationwide …

Background The durability of SARS‐CoV‐2 antibody response and the resulting immunity
to COVID‐19 is unclear. Objectives To investigate long‐term humoral immunity to SARS‐CoV‐…

Importance Sustained remission has become an achievable goal for patients with rheumatoid
arthritis (RA) receiving conventional synthetic disease-modifying antirheumatic drugs (…

Importance Proactive therapeutic drug monitoring (TDM), defined as individualized drug
dosing based on scheduled monitoring of serum drug levels, has been proposed as an …

Objective To evaluate and compare benefits and harms of three biological treatments with
different modes of action versus active conventional treatment in patients with early …

… MKA Ljosa26, … Merete Lindegaard, Heikki Relas, Heikki Valleala, Ilia Qirjazo, Inger Marie
Jensen Hansen, Jarno Rutanen, Jens Kristian Pedersen, Jens Rathmann, Johan Wallman, …